8-K: Stemtech Terminates Eevia Health RTO, Focuses on Viago Merger

Stemtech Corporation has ended its pursuit of a reverse takeover of Eevia Health Plc and is now concentrating on a merger with Viago, aiming for a listing on the Swedish MTF Nordic SME.

Summary

• Stemtech Corporation has terminated its non-binding Letter of Intent for a reverse takeover of Eevia Health Plc due to Eevia's inability to meet necessary deadlines.
• The company is now focusing on a merger with Seacret Direct, LLC d/b/a Viago.
• The merger is planned to result in a company listed on the Swedish MTF Nordic SME, part of the Nordic Growth Market.
• The proposed reverse takeover is subject to several conditions, including an exemption from the Swedish Securities Council and compliance with other regulatory requirements.
• The merger also requires the negotiation and execution of definitive agreements with mutually accepted terms.

Sentiment

Score: 4

Explanation: The document indicates a change in strategy with the termination of the Eevia Health RTO, which is a negative. However, the company is moving forward with a merger with Viago, which is a positive. The overall sentiment is slightly negative due to the uncertainty and risks associated with the new plan.

Positives

• Stemtech is moving forward with a merger plan with Viago, which they believe will be beneficial.
• The company is aiming for a listing on the Swedish MTF Nordic SME, which could provide access to new investors.

Negatives

• The termination of the Eevia Health RTO indicates a setback in Stemtech's initial plans.
• The merger with Viago is still subject to several conditions and may not be completed.

Risks

• The merger with Viago is subject to regulatory approvals and the negotiation of definitive agreements, which may not be successful.
• There is a risk that the proposed business combination could disrupt current plans and operations.
• The ability to recognize the anticipated benefits of the merger is not guaranteed and may be affected by competition and Viago's ability to grow and manage growth profitably.
• There are risks related to the costs of the proposed business combination and the ability to raise necessary financing.
• Changes in applicable laws or regulations could also impact the merger.

Future Outlook

The company is focused on completing the merger with Viago and achieving a listing on the Swedish MTF Nordic SME, but the success of this plan is subject to various conditions and risks.

Management Comments

• Stemtech and Viago remain committed to their previously disclosed agreement to merge.
• The company has determined that Eevia Health Plc could not meet the deadlines necessary to make the RTO.

Industry Context

The announcement reflects a shift in Stemtech's strategic direction, moving away from a European RTO and towards a merger with a US based company, with a listing on a Swedish exchange. This could be a move to access different capital markets or to align with a more suitable partner.

Comparison to Industry Standards

• Reverse takeovers and mergers are common strategies for companies seeking to go public or restructure their operations.
• The move to list on the Swedish MTF Nordic SME is less common than listing on major exchanges like the NYSE or NASDAQ, suggesting a specific strategic reason, possibly related to the nature of the business or the investor base.

Stakeholder Impact

• Shareholders of Stemtech will be impacted by the change in strategy and the potential merger with Viago.
• Employees of both Stemtech and Viago may be affected by the merger and integration process.
• Customers and suppliers of both companies may experience changes as a result of the merger.

Next Steps

• Negotiation and execution of definitive agreements for the merger with Viago.
• Obtaining an exemption from the obligation to make a bid from the Swedish Securities Council.
• Compliance with other regulatory requirements for the merger.
• Seeking approval from the stockholders of Stemtech and the members of Viago.

Key Dates

Keywords

merger, reverse takeover, RTO, Stemtech, Viago, Eevia Health, Swedish MTF Nordic SME, Nordic Growth Market, business combination, regulatory approvals